Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial for the Treatment of Patients with Multiple System Atrophy in Europe August 25, 2022May 23, 2023
Prana Announces that PBT2 Reduces Cognitive Impairment Caused by Tau Protein Accumulation July 17, 2013August 16, 2022